| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.400 | 25.687 | 25.592 | 40.590 | 72.317 | 66.795 |
| Total Income - EUR | - | - | - | - | 1.401 | 26.027 | 25.592 | 40.660 | 72.317 | 66.795 |
| Total Expenses - EUR | - | - | - | - | 1.021 | 14.183 | 19.187 | 20.081 | 19.547 | 28.206 |
| Gross Profit/Loss - EUR | - | - | - | - | 379 | 11.844 | 6.406 | 20.579 | 52.770 | 38.589 |
| Net Profit/Loss - EUR | - | - | - | - | 337 | 11.122 | 5.833 | 19.452 | 52.047 | 32.933 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Velcean-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 109 | 21.123 | 9.482 | 2.874 | 6.598 | 6.649 |
| Current Assets | - | - | - | - | 953 | 7.012 | 18.223 | 20.030 | 55.528 | 57.583 |
| Inventories | - | - | - | - | 0 | 389 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 297 | 1.022 | 999 | 1.029 | 14.172 | 723 |
| Cash | - | - | - | - | 656 | 5.601 | 17.224 | 19.001 | 41.356 | 56.860 |
| Shareholders Funds | - | - | - | - | 379 | 11.494 | 17.072 | 24.410 | 61.002 | 61.035 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 683 | 16.641 | 10.634 | 1.250 | 1.124 | 3.197 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Velcean-Med S.r.l.